[Hearing loss after erythromycin therapy].
We describe the case of a patient who developed bilateral loss of hearing during intravenous treatment with erythromycin. Predisposing factors may have been reduced renal and hepatic function and treatment with diuretics and aminoglycosides. Recovery was late, but hearing was probably restored to almost pre-treatment level. Patients receiving high doses of erythromycin should, as a routine, be questioned about hearing loss and tinnitus.
Lind
O
O
Ore-nese-halsavdelingen, Haukeland Sykehus, Bergen.
Harthug
S
S
D001299:Audiometry; D004917:Erythromycin / Q000008:administration & dosage / Q000009:adverse effects*; D006312:Hearing Loss, Bilateral / Q000139:chemically induced* / Q000175:diagnosis; D006801:Humans; D008297:Male; D008875:Middle Aged; D012075:Remission, Spontaneous
D004917:Erythromycin
Hørselstap etter erytromycinbehandling.